Google News: U.S. reports this development. PeeDeeWire is tracking the story and will update this page when more verified details are available.
national | tech | Google News: U.S. | June 22, 2026 3:48 PM
AbbVie to Buy Immunology Drugmaker Apogee for $10.9 Billion
AbbVie to Buy Immunology Drugmaker Apogee for $10.9 Billion WSJ AbbVie Goes On The Offensive With $10.9 Billion Takeover Investor's Business Daily AbbVie inks $10.9B Apogee buyout to bag eczema prospect Fierce Biotech AbbVie makes $10.9B move for Apogee’s long-acting I&I drug candidates Endpoints News Why AbbVie Is Spending $11 Billion to Buy Apogee Therapeutics—and Why the Stock Is Rising Barron's
Source attribution
This PeeDeeWire article is based on reporting from Google News: U.S. and links readers to the original source for full context.
Read the original source report